Title : The role of small molecule Flt3 receptor protein-tyrosine kinase inhibitors in the treatment of Flt3-positive acute myelogenous leukemias.

Pub. Date : 2020 May

PMID : 32109580






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Midostaurin is US FDA-approved in combination with standard cytarabine and daunorubicin for first-line induction chemotherapy and in combination with cytarabine for second-line consolidation chemotherapy in the treatment of acute myelogenous leukemias with FLT3-postive mutations. midostaurin fms related receptor tyrosine kinase 3 Homo sapiens